“…Using controlled and sequenced release mechanisms to prevent undesirable outcomes associated with simultaneous codelivery, local DDSs can restrict drug–drug interactions, improve therapeutic effectiveness, and minimize drug resistance in skin cancer treatment. − The field of sequential and on-demand DDSs has seen a growth in the development of responsive biomaterials with configurable physical and chemical characteristics. − Because of their reversible phase transformation in reaction to stimulation and physiochemical influences such as pH, temperature, and enzymatic activity, and external forces such as UV light, near-infrared (NIR), ultrasound, electric, and magnetic radiation, these materials can be used as drug-carrier frameworks for the effective delivery of pharmaceuticals. − Because most drugs must be given repeatedly and consistently over long periods of time to be effective, and their concentrations must remain within the desired effective range to prevent overuse or underdosing, it is necessary to develop and improve new adaptive systems that can be easily controlled externally and capable of being spatially programmed. ,, …”